Decasone Injection 4 mg/ml INJECTION
PDF Leaflet Revision Date: 29 January 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Anti-inflammatory and immunosuppressive therapy, including COVID-19 treatment.
Dosage (summary)
0.5 to 20 mg daily; 6 mg IV once daily for COVID-19 up to 10 days.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Crosses placenta; may cause fetal adrenal suppression. Not recommended during breastfeeding.
Key Drug Interactions
- Liver enzyme inducers may reduce efficacy
- Potassium-depleting diuretics may cause hypokalaemia
Contraindications
- Hypersensitivity to dexamethasone
- Active tuberculosis
- Ocular herpes simplex
- Systemic infections
Common side effects
- Psychiatric disorders
- Hypertension
- Gastrointestinal ulceration
- Osteoporosis
Counselling Points
- Monitor for psychiatric symptoms
- Avoid live vaccines
- Carry steroid treatment card
Serious warnings
- Risk of anaphylaxis
- Adrenal suppression on withdrawal
- Increased infection risk
Important Disclaimer
The Decasone Injection 4 mg/ml INJECTION professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
